A 59-year-old man with a history of myocardial infarction 2 years ago undergoes an uneventful aoobifemoral bypass graft for aooiliac occlusive disease. Six hours later he develops ST segment depression, and a 12-lead electrocardiogram (ECG) shows anterolateral ischemia. His hemodynamic parameters are as follows: systemic BP 70/40 mm Hg, pulse 100 beats per minute, CVP 18 mm Hg, PCWP 25 mm Hg, cardiac output 1.5 L/min, and systemic vascular resistance 1000 (dyne * s)/cm5 . Which of the following is the single best pharmacologic intervention for this patient?
A 59-year-old man with a history of myocardial infarction 2 years ago undergoes an uneventful aoobifemoral bypass graft for aooiliac occlusive disease. Six hours later he develops ST segment depression, and a 12-lead electrocardiogram (ECG) shows anterolateral ischemia. His hemodynamic parameters are as follows: systemic BP 70/40 mm Hg, pulse 100 beats per minute, CVP 18 mm Hg, PCWP 25 mm Hg, cardiac output 1.5 L/min, and systemic vascular resistance 1000 (dyne * s)/cm5 . Which of the following is the single best pharmacologic intervention for this patient?
💡 Explanation
**Core Concept**
The patient is experiencing cardiogenic shock, a condition characterized by the inability of the heart to pump enough blood to meet the body's needs, often due to decreased cardiac function and/or increased afterload. In this scenario, the patient's systemic vascular resistance is elevated, which further impairs cardiac output.
**Why the Correct Answer is Right**
The patient's elevated systemic vascular resistance and decreased cardiac output indicate that he is experiencing a high afterload state, which is not adequately addressed by increasing preload (e.g., with fluids). The use of vasodilators, specifically nitroprusside, can help decrease systemic vascular resistance, thereby reducing afterload and improving cardiac output. Nitroprusside works by releasing nitric oxide, which then activates guanylyl cyclase, leading to the production of cyclic GMP, a potent vasodilator. This results in the relaxation of vascular smooth muscle, causing vasodilation and a decrease in systemic vascular resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** Inotropes (e.g., dobutamine) may increase cardiac contractility but do not address the underlying issue of elevated afterload. While they may temporarily improve cardiac output, they do not provide a long-term solution to the patient's hemodynamic instability.
**Option B:** Fluid administration may increase preload, which could potentially worsen the patient's condition by further increasing afterload. This is known as the Frank-Starling mechanism, where increased preload leads to increased stroke volume, but only up to a point. In this case, the patient's elevated systemic vascular resistance and decreased cardiac output indicate that he is operating beyond this point.
**Option C:** Beta-blockers would be contraindicated in this scenario as they would further decrease cardiac contractility and increase systemic vascular resistance, exacerbating the patient's condition.
**Option D:** This option is incomplete, but if it refers to a vasopressor (e.g., norepinephrine), it would be incorrect as it would further increase systemic vascular resistance, worsening the patient's condition.
**Clinical Pearl / High-Yield Fact**
In cardiogenic shock, it is essential to differentiate between preload-dependent and afterload-dependent states. The use of vasodilators, such as nitroprusside, can be life-saving in patients with elevated afterload, whereas inotropes and vasopressors may worsen the patient's condition.
**Correct Answer: C. Nitroprusside is the single best pharmacologic intervention for this patient.**
✓ Correct Answer: D. Dobutamine
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram